(Q28297610)

1

0 references

Chiara Riganti

2

0 references

Claudia Voena

3

0 references

Costanzo Costamagna

4

0 references

Elisabetta Aldieri

5

0 references

Gianpiero Pescarmona

6

0 references

Dario Ghigo

7

0 references

Amalia Bosia

Molecular Cancer Research

8

0 references

language of work or name

English

0 references

publication date

October 2008

0 references

published in

0 references

volume

6

0 references

issue

10

0 references

page(s)

1607-20

0 references

cites work

Cell biological mechanisms of multidrug resistance in tumors

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

MDR1 gene expression in solid tumours

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Simvastatin prevents oxygen and glucose deprivation/reoxygenation-induced death of cortical neurons by reducing the production and toxicity of 4-hydroxy-2E-nonenal

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

RhoA regulation of NF-kappaB activation is mediated by COX-2-dependent feedback inhibition of IKK in kidney epithelial cells

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Role of ABCC1 in export of sphingosine-1-phosphate from mast cells

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

S-nitrosylation in health and disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Differential phosphorylation of the signal-responsive domain of I kappa B alpha and I kappa B beta by I kappa B kinases

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Simvastatin potentiates TNF-alpha-induced apoptosis through the down-regulation of NF-kappaB-dependent antiapoptotic gene products: role of IkappaBalpha kinase and TGF-beta-activated kinase-1.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Drug resistance reversal--are we getting closer?

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Cardiac toxicity of daunorubicin

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Mechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Multidrug resistance in cancer: role of ATP-dependent transporters

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Rho GTPases: promising cellular targets for novel anticancer drugs

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Simvastatin enhances induction of inducible nitric oxide synthase in 3T3-L1 adipocytes

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Simian virus 40 infection down-regulates the expression of nitric oxide synthase in human mesothelial cells

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1158/1541-7786.MCR-08-0251

Identifiers

DOI

10.1158/1541-7786.MCR-08-0251

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18922976

1 reference

stated in